Midatech Pharma plc - Special Call Transcript
Well, good afternoon, everybody. It seems most people have joined now. Welcome to the Midatech Pharma question-and-answer session. Today, I've got Stephen Stamp, CEO and CFO; and Steve Damment, Executive Vice President of R&D, with me.
The session is specifically to answer questions on the announcement this morning. Steve and Stephen will give some introductory remarks. We will then move to the question-and-answer session. (Operator Instructions) So on that basis, I'll hand over to Stephen to start the session. Stephen?
Thank you, Tim, and good afternoon, everybody, in the U.K. and good morning, colleagues, in the U.S. Very pleased to have made this morning's announcement, very exciting news for a very important program of Midatech, MTX110 in DIPG. I don't intend to steal any of his thunder, so I'm going to pass you straight on to Steve Damment, our EVP of R&D. Steve?
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
